Posted on: 20 August 2015

(1) On request from clinicians, Cyclotek validates the GMP production of FCH;
(2) GE Healthcare and Cyclotek sign Statement of Work for the evaluation of stability of the Nb targets for the MINItrace at 70µA;
(3) Increase capacity of PETtrace cyclotron from 100µA to130µA.

[contact-form-7 id=”714″ title=”Update Form”]